Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Raphael Dolin, M.D.

TitleMaxwell Finland Professor of Medicine (Microbiology and Molecular Genetics)
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine
AddressBeth Israel Deaconess Medical Center
Division of Viral Pathogenesis, E/CLS-1003
330 Brookline Ave
Boston MA 02215
Phone617/735-4424
Fax617/432-3635
Other Positions
TitleProfessor of Medicine
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Walsh SR, Seaman MS, Grandpre LE, Charbonneau C, Yanosick KE, Metch B, Keefer MC, Dolin R, Baden LR. Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 2012 Dec 17; 31(1):114-9.
    View in: PubMed
  2. Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, Alter G, Chung A, Dugast AS, Frahm N, McElrath MJ, Wenschuh H, Reimer U, Seaman MS, Pau MG, Weijtens M, Goudsmit J, Walsh SR, Dolin R, Baden LR. Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001). J Infect Dis. 2013 Jan; 207(2):248-56.
    View in: PubMed
  3. Baden LR, Walsh SR, Seaman MS, Tucker RP, Krause KH, Patel A, Johnson JA, Kleinjan J, Yanosick KE, Perry J, Zablowsky E, Abbink P, Peter L, Iampietro MJ, Cheung A, Pau MG, Weijtens M, Goudsmit J, Swann E, Wolff M, Loblein H, Dolin R, Barouch DH. First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001). J Infect Dis. 2013 Jan; 207(2):240-7.
    View in: PubMed
  4. Baden LR, Dolin R. The road to an effective HIV vaccine. N Engl J Med. 2012 Apr 5; 366(14):1343-4.
    View in: PubMed
  5. Baden LR, Blattner WA, Morgan C, Huang Y, Defawe OD, Sobieszczyk ME, Kochar N, Tomaras GD, McElrath MJ, Russell N, Brandariz K, Cardinali M, Graham BS, Barouch DH, Dolin R. Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. J Infect Dis. 2011 Nov 15; 204(10):1541-9.
    View in: PubMed
  6. Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). PLoS One. 2011; 6(8):e21225.
    View in: PubMed
  7. Walsh SR, Dolin R. Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors. Expert Rev Vaccines. 2011 Aug; 10(8):1221-40.
    View in: PubMed
  8. Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine. 2011 Jul 18; 29(32):5203-9.
    View in: PubMed
  9. Dolin R. Resistance to neuraminidase inhibitors. Clin Infect Dis. 2011 Feb 15; 52(4):438-9.
    View in: PubMed
  10. Dolin R. Editorial commentary: Perspectives on the role of immunization against influenza in HIV-infected patients. Clin Infect Dis. 2011 Jan 1; 52(1):147-9.
    View in: PubMed
  11. Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R. Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. J Infect Dis. 2010 May 1; 201(9):1361-70.
    View in: PubMed
  12. Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R. Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. J Infect Dis. 2010 May 1; 201(9):1353-60.
    View in: PubMed
  13. Dolin R. HIV vaccine trial results--an opening for further research. N Engl J Med. 2009 Dec 3; 361(23):2279-80.
    View in: PubMed
  14. Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, Letvin NL, Reinherz EL, Baden LR, Dolin R, Seaman MS. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Vaccine. 2009 Mar 4; 27(10):1549-56.
    View in: PubMed
  15. Duke-Cohan JS, Wollenick K, Witten EA, Seaman MS, Baden LR, Dolin R, Reinherz EL. The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays. Vaccine. 2009 Feb 18; 27(8):1154-65.
    View in: PubMed
  16. Dolin R. A new class of anti-HIV therapy and new challenges. N Engl J Med. 2008 Oct 2; 359(14):1509-11.
    View in: PubMed
  17. Dolin R. Noroviruses--challenges to control. N Engl J Med. 2007 Sep 13; 357(11):1072-3.
    View in: PubMed
  18. Dolin R. Influenza--interpandemic as well as pandemic disease. N Engl J Med. 2005 Dec 15; 353(24):2535-7.
    View in: PubMed
  19. Dolin R, Blacklow NR, DuPont H, Formal S, Buscho RF, Kasel JA, Chames RP, Hornick R, Chanock RM. Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. 1971. J Infect Dis. 2004 Jun 1; 189(11):2142-7, discussion 2139-41.
    View in: PubMed
  20. Gupta K, Hudgens M, Corey L, McElrath MJ, Weinhold K, Montefiori DC, Gorse GJ, Frey SE, Keefer MC, Evans TG, Dolin R, Schwartz DH, Harro C, Graham B, Spearman PW, Mulligan M, Goepfert P. Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. J Acquir Immune Defic Syndr. 2002 Mar 1; 29(3):254-61.
    View in: PubMed
  21. Dolin R. HIV vaccines for prevention of infection and disease in humans. Infect Dis Clin North Am. 2000 Dec; 14(4):1001-16.
    View in: PubMed
  22. McElrath MJ, Corey L, Montefiori D, Wolff M, Schwartz D, Keefer M, Belshe R, Graham BS, Matthews T, Wright P, Gorse G, Dolin R, Berman P, Francis D, Duliege AM, Bolognesi D, Stablein D, Ketter N, Fast P. A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses. 2000 Jun 10; 16(9):907-19.
    View in: PubMed
  23. Dolin R. Enterovirus 71--emerging infections and emerging questions. N Engl J Med. 1999 Sep 23; 341(13):984-5.
    View in: PubMed
  24. Dolin R. Gaining ground in progressive multifocal leukoencephalopathy. Neurology. 1999 Feb; 52(3):440-1.
    View in: PubMed
  25. Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S, Mascola J, Schwartz D, Siliciano R, Corey L, Wright PF, Belshe R, Dolin R, Jackson S, Xu S, Fast P, Walker MC, Stablein D, Excler JL, Tartaglia J, Paoletti E, et al. Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis. 1998 May; 177(5):1230-46.
    View in: PubMed
  26. Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF, Korber BT, Wolff MC, Fast PE. Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis. 1998 Feb; 177(2):310-9.
    View in: PubMed
  27. Raboud JM, Montaner JS, Rae S, Kahn J, Hammer SM, Katzenstein DA, Pavia A, Dolin R, Hughes MD, Cross A, Beltangady M, Gatell J, Dunkle L, Smaldone L. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antivir Ther. 1997 Dec; 2(4):237-47.
    View in: PubMed
  28. Spino C, Kahn JO, Dolin R, Phair JP. Predictors of survival in HIV-infected persons with 50 or fewer CD4 cells/mm3. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 15; 15(5):346-55.
    View in: PubMed
  29. Krogstad DJ, Pearson RD, Bennett JE, Dolin R, Mandell GL. Dosage for malaria treatment. Lancet. 1996 Nov 9; 348(9037):1311; author reply 1311-2.
    View in: PubMed
  30. Welles SL, Jackson JB, Yen-Lieberman B, Demeter L, Japour AJ, Smeaton LM, Johnson VA, Kuritzkes DR, D'Aquila RT, Reichelderfer PA, Richman DD, Reichman R, Fischl M, Dolin R, Coombs RW, Kahn JO, McLaren C, Todd J, Kwok S, Crumpacker CS. Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. J Infect Dis. 1996 Oct; 174(4):696-703.
    View in: PubMed
  31. Keefer MC, Graham BS, McElrath MJ, Matthews TJ, Stablein DM, Corey L, Wright PF, Lawrence D, Fast PE, Weinhold K, Hsieh RH, Chernoff D, Dekker C, Dolin R. Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses. 1996 May 20; 12(8):683-93.
    View in: PubMed
  32. Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D. Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1; 12(1):38-45.
    View in: PubMed
  33. Gorse GJ, Keefer MC, Belshe RB, Matthews TJ, Forrest BD, Hsieh RH, Koff WC, Hanson CV, Dolin R, Weinhold KJ, Frey SE, Ketter N, Fast PE. A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1996 Feb; 173(2):330-9.
    View in: PubMed
  34. Dolin RH. Internet medical resources. Ann Intern Med. 1996 Feb 1; 124(3):375.
    View in: PubMed
  35. Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, McCutchan FE, Burke DS. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. J Infect Dis. 1996 Feb; 173(2):340-8.
    View in: PubMed
  36. Demeter LM, Nawaz T, Morse G, Dolin R, Dexter A, Gerondelis P, Reichman RC. Development of zidovudine resistance mutations in patients receiving prolonged didanosine monotherapy. J Infect Dis. 1995 Dec; 172(6):1480-5.
    View in: PubMed
  37. Dolin R. Human studies in the development of human immunodeficiency virus vaccines. J Infect Dis. 1995 Nov; 172(5):1175-83.
    View in: PubMed
  38. Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Liou SH, Brown MJ, Cross AP, Hirsch MS, Hardy WD, et al. Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group. Arch Intern Med. 1995 May 8; 155(9):961-74.
    View in: PubMed
  39. Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, Dolin R, et al. Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network. J Infect Dis. 1994 Oct; 170(4):782-6.
    View in: PubMed
  40. Belshe RB, Bolognesi DP, Clements ML, Corey L, Dolin R, Mestecky J, Mulligan M, Stablein D, Wright P. HIV infection in vaccinated volunteers. JAMA. 1994 Aug 10; 272(6):431.
    View in: PubMed
  41. Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, Weinhold K, Bolognesi DP, Sposto R, et al. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. JAMA. 1994 Aug 10; 272(6):475-80.
    View in: PubMed
  42. Grasela TH, Walawander CA, Beltangady M, Knupp CA, Martin RR, Dunkle LM, Barbhaiya RH, Pittman KA, Dolin R, Valentine FT, et al. Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine. J Infect Dis. 1994 Jun; 169(6):1250-5.
    View in: PubMed
  43. Dolin RH, Stringer WW. Timing of BAL in suspected PCP. J Gen Intern Med. 1994 Jun; 9(6):356.
    View in: PubMed
  44. Belshe RB, Clements ML, Dolin R, Graham BS, McElrath J, Gorse GJ, Schwartz D, Keefer MC, Wright P, Corey L, et al. Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network. J Infect Dis. 1993 Dec; 168(6):1387-95.
    View in: PubMed
  45. el-Daher N, Keefer MC, Reichman RC, Dolin R, Roberts NJ. Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines. J Infect Dis. 1993 Aug; 168(2):306-13.
    View in: PubMed
  46. Reichman RC, Tejani N, Lambert JL, Strussenberg J, Bonnez W, Blumberg B, Epstein L, Dolin R. Didanosine (ddI) and zidovudine (ZDV) susceptibilities of human immunodeficiency virus (HIV) isolates from long-term recipients of ddI. Antiviral Res. 1993 Apr; 20(4):267-77.
    View in: PubMed
  47. Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP, et al. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J Infect Dis. 1993 Mar; 167(3):533-7.
    View in: PubMed
  48. Lambert JS, Seidlin M, Valentine FT, Reichman RC, Dolin R. Didanosine: long-term follow-up of patients in a phase 1 study. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S40-5.
    View in: PubMed
  49. McLaren C, Rozencweig M, Beltangady M, Nicaise C, Yarchoan R, Dolin R, Allan JD, Cooley TP, Seidlin M, Smaldone LF. Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virus. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S32-9.
    View in: PubMed
  50. Beltangady M, Knupp CA, Gustafson N, Barbhaiya RH, Dolin R, Seidlin M, Cooley TP, Rozencweig M. Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S26-31.
    View in: PubMed
  51. Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, Dolin R, Kelley S, Lambert J, Liebman HA, et al. Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood. 1992 Dec 15; 80(12):2969-76.
    View in: PubMed
  52. Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med. 1992 Oct 15; 117(8):625-33.
    View in: PubMed
  53. Graham BS, Belshe RB, Clements ML, Dolin R, Corey L, Wright PF, Gorse GJ, Midthun K, Keefer MC, Roberts NJ, et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis. 1992 Aug; 166(2):244-52.
    View in: PubMed
  54. Seidlin M, Lambert JS, Dolin R, Valentine FT. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS. 1992 Aug; 6(8):831-5.
    View in: PubMed
  55. Madore HP, Christy C, Pichichero M, Long C, Pincus P, Vosefsky D, Kapikian AZ, Dolin R. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups. J Infect Dis. 1992 Aug; 166(2):235-43.
    View in: PubMed
  56. Drusano GL, Yuen GJ, Morse G, Cooley TP, Seidlin M, Lambert JS, Liebman HA, Valentine FT, Dolin R. Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials. Antimicrob Agents Chemother. 1992 Jun; 36(6):1280-3.
    View in: PubMed
  57. Drusano GL, Yuen GJ, Lambert JS, Seidlin M, Dolin R, Valentine FT. Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial. Ann Intern Med. 1992 Apr 1; 116(7):562-6.
    View in: PubMed
  58. Pai SM, Shukla UA, Grasela TH, Knupp CA, Dolin R, Valentine FT, McLaren C, Liebman HA, Martin RR, Pittman KA, et al. Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complex. J Clin Pharmacol. 1992 Mar; 32(3):242-7.
    View in: PubMed
  59. Kieburtz KD, Seidlin M, Lambert JS, Dolin R, Reichman R, Valentine F. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr. 1992; 5(1):60-4.
    View in: PubMed
  60. Kapikian AZ, Vesikari T, Ruuska T, Madore HP, Christy C, Dolin R, Flores J, Green KY, Davidson BL, Gorziglia M, et al. An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea. Adv Exp Med Biol. 1992; 327:59-69.
    View in: PubMed
  61. Knupp CA, Shyu WC, Dolin R, Valentine FT, McLaren C, Martin RR, Pittman KA, Barbhaiya RH. Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex. Clin Pharmacol Ther. 1991 May; 49(5):523-35.
    View in: PubMed
  62. Keefer MC, Bonnez W, Roberts NJ, Dolin R, Reichman RC. Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients. J Infect Dis. 1991 Mar; 163(3):448-53.
    View in: PubMed
  63. Dolin R, Graham BS, Greenberg SB, Tacket CO, Belshe RB, Midthun K, Clements ML, Gorse GJ, Horgan BW, Atmar RL, et al. The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. Ann Intern Med. 1991 Jan 15; 114(2):119-27.
    View in: PubMed
  64. Madore HP, Treanor JJ, Buja R, Dolin R. Antigenic relatedness among the Norwalk-like agents by serum antibody rises. J Med Virol. 1990 Oct; 32(2):96-101.
    View in: PubMed
  65. Dolin R, Lambert JS, Morse GD, Reichman RC, Plank CS, Reid J, Knupp C, McLaren C, Pettinelli C. 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex. Rev Infect Dis. 1990 Jul-Aug; 12 Suppl 5:S540-9; discussion S549-51.
    View in: PubMed
  66. Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med. 1990 May 15; 112(10):727-37.
    View in: PubMed
  67. Gordon SM, Oshiro LS, Jarvis WR, Donenfeld D, Ho MS, Taylor F, Greenberg HB, Glass R, Madore HP, Dolin R, et al. Foodborne Snow Mountain agent gastroenteritis with secondary person-to-person spread in a retirement community. Am J Epidemiol. 1990 Apr; 131(4):702-10.
    View in: PubMed
  68. Dolin R. Current concepts of control measures for influenza. Trans Am Clin Climatol Assoc. 1990; 101:227-33.
    View in: PubMed
  69. Treanor JJ, Madore HP, Dolin R. Development of an enzyme immunoassay for the Hawaii agent of viral gastroenteritis. J Virol Methods. 1988 Dec; 22(2-3):207-14.
    View in: PubMed
  70. Christy C, Madore HP, Pichichero ME, Gala C, Pincus P, Vosefski D, Hoshino Y, Kapikian A, Dolin R. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J. 1988 Sep; 7(9):645-50.
    View in: PubMed
  71. Treanor J, Dolin R, Madore HP. Production of a monoclonal antibody against the Snow Mountain agent of gastroenteritis by in vitro immunization of murine spleen cells. Proc Natl Acad Sci U S A. 1988 May; 85(10):3613-7.
    View in: PubMed
  72. Snyder MH, Betts RF, DeBorde D, Tierney EL, Clements ML, Herrington D, Sears SD, Dolin R, Maassab HF, Murphy BR. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines. J Virol. 1988 Feb; 62(2):488-95.
    View in: PubMed
  73. Dolin R. Genital lesions and aseptic meningitis. Hosp Pract (Off Ed). 1987 Oct 30; 22(10A):27-37.
    View in: PubMed
  74. Truman BI, Madore HP, Menegus MA, Nitzkin JL, Dolin R. Snow Mountain agent gastroenteritis from clams. Am J Epidemiol. 1987 Sep; 126(3):516-25.
    View in: PubMed
  75. Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans. J Infect Dis. 1987 Aug; 156(2):379-83.
    View in: PubMed
  76. Hall CB, Dolin R, Gala CL, Markovitz DM, Zhang YQ, Madore PH, Disney FA, Talpey WB, Green JL, Francis AB, et al. Children with influenza A infection: treatment with rimantadine. Pediatrics. 1987 Aug; 80(2):275-82.
    View in: PubMed
  77. Guest C, Spitalny KC, Madore HP, Pray K, Dolin R, Herrmann JE, Blacklow NR. Foodborne Snow Mountain agent gastroenteritis in a school cafeteria. Pediatrics. 1987 Apr; 79(4):559-63.
    View in: PubMed
  78. Dolin R, Treanor JJ, Madore HP. Novel agents of viral enteritis in humans. J Infect Dis. 1987 Mar; 155(3):365-76.
    View in: PubMed
  79. Christy C, Madore HP, Treaner JJ, Pray K, Kapikian AZ, Chanock RM, Dolin R. Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine. J Infect Dis. 1986 Dec; 154(6):1045-7.
    View in: PubMed
  80. Madore HP, Treanor JJ, Pray KA, Dolin R. Enzyme-linked immunosorbent assays for Snow Mountain and Norwalk agents of viral gastroenteritis. J Clin Microbiol. 1986 Sep; 24(3):456-9.
    View in: PubMed
  81. Dolin R, Roessner KD, Treanor JJ, Reichman RC, Phillips M, Madore HP. Radioimmunoassay for detection of the Snow Mountain Agent of viral gastroenteritis. J Med Virol. 1986 May; 19(1):11-8.
    View in: PubMed
  82. Snyder MH, Clements ML, Betts RF, Dolin R, Buckler-White AJ, Tierney EL, Murphy BR. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. J Clin Microbiol. 1986 May; 23(5):852-7.
    View in: PubMed
  83. Madore HP, Treanor JJ, Dolin R. Characterization of the Snow Mountain agent of viral gastroenteritis. J Virol. 1986 May; 58(2):487-92.
    View in: PubMed
  84. Brondum J, Spitalny KC, Vogt RL, Godlewski K, Madore HP, Dolin R. Snow Mountain agent associated with an outbreak of gastroenteritis in Vermont. J Infect Dis. 1985 Oct; 152(4):834-7.
    View in: PubMed
  85. Dolin R. Antiviral chemotherapy and chemoprophylaxis. Science. 1985 Mar 15; 227(4692):1296-303.
    View in: PubMed
  86. Whitley RJ, Soong SJ, Alford CA, Hirsch MS, Schooley R, Oxman MN, Connor JD, Betts R, Dolin R, Reichman RC. Design of therapeutic studies in herpes simplex encephalitis. Lancet. 1985 Feb 2; 1(8423):284-5.
    View in: PubMed
  87. Mertz GJ, Critchlow CW, Benedetti J, Reichman RC, Dolin R, Connor J, Redfield DC, Savoia MC, Richman DD, Tyrrell DL, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA. 1984 Sep 7; 252(9):1147-51.
    View in: PubMed
  88. Murphy BR, Clements ML, Madore HP, Steinberg J, O'Donnell S, Betts R, Demico D, Reichman RC, Dolin R, Maassab HF. Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers. J Infect Dis. 1984 May; 149(5):816.
    View in: PubMed
  89. Skevakis L, Frasch CE, Zahradnik JM, Dolin R. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. J Infect Dis. 1984 Mar; 149(3):387-96.
    View in: PubMed
  90. Madore HP, Reichman RC, Dolin R. Serum antibody responses in naturally occurring influenza A virus infection determined by enzyme-linked immunosorbent assay, hemagglutination inhibition, and complement fixation. J Clin Microbiol. 1983 Dec; 18(6):1345-50.
    View in: PubMed
  91. Quinnan GV, Schooley R, Dolin R, Ennis FA, Gross P, Gwaltney JM. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis. 1983 Jul-Aug; 5(4):748-57.
    View in: PubMed
  92. Reichman RC, Badger GJ, Guinan ME, Nahmias AJ, Keeney RE, Davis LG, Ashikaga T, Dolin R. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis. 1983 Feb; 147(2):336-40.
    View in: PubMed
  93. Kapikian AZ, Wyatt RG, Levine MM, Yolken RH, VanKirk DH, Dolin R, Greenberg HB, Chanock RM. Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J Infect Dis. 1983 Jan; 147(1):95-106.
    View in: PubMed
  94. Cole J, Dolin R, Fahrner K, Gallenson N, Hall J, Harris W. Retinofugal pathways from albino eyes embryonically transplanted to normal and albino axolotls. Brain Res. 1982 Nov; 281(3):346-9.
    View in: PubMed
  95. Whitley RJ, Soong SJ, Dolin R, Betts R, Linnemann C, Alford CA. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med. 1982 Oct 14; 307(16):971-5.
    View in: PubMed
  96. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med. 1982 Sep 2; 307(10):580-4.
    View in: PubMed
  97. Dolin R, Reichman RC, Roessner KD, Tralka TS, Schooley RT, Gary W, Morens D. Detection by immune electron microscopy of the Snow Mountain agent of acute viral gastroenteritis. J Infect Dis. 1982 Aug; 146(2):184-9.
    View in: PubMed
  98. Reichman RC, Ginsberg M, Barrett-Connor E, Wyborny C, Connor JD, Redfield D, Savoia MC, Richman DD, Oxman MN, Dandliker PS, Badger GJ, Ashikaga T, Dolin R. Controlled trial of oral acyclovir in the therapy of recurrent herpes simplex genitalis. A preliminary report. Am J Med. 1982 Jul 20; 73(1A):338-41.
    View in: PubMed
  99. Reichman RC, Fisher SE, Dolin R. Lymphocyte responses to herpes simplex virus isolates from patients with primary and recurrent herpes simplex genitalis. Am J Med. 1982 Jul 20; 73(1A):86-90.
    View in: PubMed
  100. Alford CA, Dolin R, Hirsch MS, Karchmer AW, Whitley RJ. Herpes simplex encephalitis and clinical trial design. Lancet. 1982 May 1; 1(8279):1013.
    View in: PubMed
  101. Blackwelder WC, Dolin R, Mittal KK, McNamara PM, Payne FJ. A population study of herpesvirus infections and HLA antigens. Am J Epidemiol. 1982 Apr; 115(4):569-76.
    View in: PubMed
  102. Girod JC, Reichman RC, Winn WC, Klaucke DN, Vogt RL, Dolin R. Pneumonic and nonpneumonic forms of legionellosis. The result of a common-source exposure to Legionella pneumophila. Arch Intern Med. 1982 Mar; 142(3):545-7.
    View in: PubMed
  103. Schooley RT, Haynes BF, Grouse J, Payling-Wright C, Fauci AS, Dolin R. Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems. Blood. 1981 Mar; 57(3):510-7.
    View in: PubMed
  104. Whitley RJ, Soong SJ, Hirsch MS, Karchmer AW, Dolin R, Galasso G, Dunnick JK, Alford CA. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981 Feb 5; 304(6):313-8.
    View in: PubMed
  105. Schooley RT, Haynes BF, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS. Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. Cell Immunol. 1980 Dec; 56(2):518-25.
    View in: PubMed
  106. Morens DM, Bregman DJ, West CM, Greene MH, Mazur MH, Dolin R, Fisher RI. An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med. 1980 Sep; 93(3):414-9.
    View in: PubMed
  107. Reichman RC, Dolin R. Viral pneumonias. Med Clin North Am. 1980 May; 64(3):491-506.
    View in: PubMed
  108. Berg RA, Yolken RH, Rennard SI, Dolin R, Murphy BR, Straus SE. New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet. 1980 Apr 19; 1(8173):851-3.
    View in: PubMed
  109. Pons VG, Canter J, Dolin R. Influenza A/USSR/77 (H1N1) on a university campus. Am J Epidemiol. 1980 Jan; 111(1):23-30.
    View in: PubMed
  110. Mazur MH, Whitley RJ, Dolin R. Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979 Dec; 139(12):1341-5.
    View in: PubMed
  111. Haynes BF, Schooley RT, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS. Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Nov; 123(5):2095-101.
    View in: PubMed
  112. Dolin R. Nathaniel A. Young, 1939--1979. J Infect Dis. 1979 Aug; 140(2):271-2.
    View in: PubMed
  113. Morens DM, Zweighaft RM, Vernon TM, Gary GW, Eslien JJ, Wood BT, Holman RC, Dolin R. A waterborne outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent. Lancet. 1979 May 5; 1(8123):964-6.
    View in: PubMed
  114. Haynes BF, Schooley RT, Grouse JE, Payling-Wright CR, Dolin R, Fauci AS. Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Feb; 122(2):699-702.
    View in: PubMed
  115. Dolin R. Amantadine and influenza A. Am Fam Physician. 1979 Jan; 19(1):127-30.
    View in: PubMed
  116. Pons VG, Reinertsen JL, Steinberg AD, Dolin R. Decreased cell-mediated cytotoxicity against virus-infected cells in systemic lupus erythematosus. J Med Virol. 1979; 4(1):15-23.
    View in: PubMed
  117. Reichman RC, Pons VG, Murphy BR, Caplan EA, Dolin R. Cell-mediated cytotoxicity following influenza infection and vaccination in humans. J Med Virol. 1979; 4(1):1-14.
    View in: PubMed
  118. Mazur MH, Dolin R. Herpes zoster at the NIH: a 20 year experience. Am J Med. 1978 Nov; 65(5):738-44.
    View in: PubMed
  119. Dolin R, Reichman RC, Mazur MH, Whitley RJ. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep; 89(3):375-88.
    View in: PubMed
  120. Dolin R. Norwalk agent-like particles associated with gastroenteritis in human beings. J Am Vet Med Assoc. 1978 Sep 1; 173(5 Pt 2):615-9.
    View in: PubMed
  121. Williams GW, Steinberg AD, Reinertsen JL, Klassen LW, Decker JL, Dolin R. Influenza immunization in systemic lupus eruthematosus. A double-blind trial. Ann Intern Med. 1978 Jun; 88(6):729-34.
    View in: PubMed
  122. Dolin R, Murphy BR, Caplan EA. Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans. Infect Immun. 1978 Mar; 19(3):867-74.
    View in: PubMed
  123. Wise TG, Dolin R, Mazur MH, Top FH, Edelman R, Ennis FA. Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines. J Infect Dis. 1977 Dec; 136 Suppl:S507-17.
    View in: PubMed
  124. Wise TG, Dolin R, Mazur MH, Ennis FA. Serologic responses after two sequential doses of influenza A/New Jersey/76 virus vaccine in normal young adults. J Infect Dis. 1977 Dec; 136 Suppl:S496-9.
    View in: PubMed
  125. Dolin R, Wise TG, Mazur MH, Tuazon CU, Ennis FA. Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis. 1977 Dec; 136 Suppl:S435-42.
    View in: PubMed
  126. Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch'ien LT, Alford CA. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. J Med Assoc State Ala. 1977 Sep; 47(3):37-42, 66.
    View in: PubMed
  127. Reichman RC, Dolin R, Vincent MM, Fauci AS. Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man. Proc Soc Exp Biol Med. 1977 Sep; 155(4):571-6.
    View in: PubMed
  128. Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch'ien LT, Alford CA. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11; 297(6):289-94.
    View in: PubMed
  129. Chusid MJ, Fauci AS, Dolin R. Effect of virus infection on polymorphonuclear leucocytes. Lancet. 1977 May 21; 1(8021):1110-1.
    View in: PubMed
  130. Dolin R, Richman DD, Murphy BR, Fauci AS. Cell-mediated immune responses in humans after induced infection with influenza A virus. J Infect Dis. 1977 May; 135(5):714-9.
    View in: PubMed
  131. Coker-Vann M, Dolin R. Effect of adenine arabinoside on Epstein-Barr virus in vitro. J Infect Dis. 1977 Mar; 135(3):447-53.
    View in: PubMed
  132. Thornhill TS, Wyatt RG, Kalica AR, Dolin R, Chanock RM, Kapikian AZ. Detection by immune electron microscopy of 26- to 27-nm viruslike particles associated with two family outbreaks of gastroenteritis. J Infect Dis. 1977 Jan; 135(1):20-7.
    View in: PubMed
  133. Houff SA, Miller GL, Lovell CR, Wallen WC, Madden DL, Sever JL, Dolin R. The Guillain-Barré Syndrome and swine influenza vaccination. Trans Am Neurol Assoc. 1977; 102:120-3.
    View in: PubMed
  134. Wright PF, Dolin R, La Montagne JR. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. J Infect Dis. 1976 Dec; 134(6):633-8.
    View in: PubMed
  135. Dolin R. Influenza: current concepts. Am Fam Physician. 1976 Sep; 14(3):72-7.
    View in: PubMed
  136. Dolin R, Reichman RC, Fauci AS. Lymphocyte populations in acute viral gastroenteritis. Infect Immun. 1976 Aug; 14(2):422-8.
    View in: PubMed
  137. Whitley RJ, Ch'ien LT, Dolin R, Galasso GJ, Alford CA. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9.
    View in: PubMed
  138. Levy AG, Widerlite L, Schwartz CJ, Dolin R, Blacklow NR, Gardner JD, Kimberg DV, Trier JS. Jejunal adenylate cyclase activity in human subjects during viral gastroenteritis. Gastroenterology. 1976 Mar; 70(3):321-5.
    View in: PubMed
  139. Bagely DH, Alexander JC, Gill VJ, Dolin R, Ketcham AS. Late Flavobacterium species meningitis after craniofacial exenteration. Arch Intern Med. 1976 Feb; 136(2):229-31.
    View in: PubMed
  140. Dolin R, Levy AG, Wyatt RG, Thornhill TS, Gardner JD. Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. Am J Med. 1975 Dec; 59(6):761-8.
    View in: PubMed
  141. Dolin R, Gill FA, Nahmias AJ. Genital herpes simplex virus type 1 infection--variability in modes of spread. J Am Vener Dis Assoc. 1975 Dec; 2(2):13-6.
    View in: PubMed
  142. Dolin R, Baron S. Absence of detectable interferon in jejunal biopsies, jejunal aspirates, and sera in experimentally induced viral gastroenteritis in man. Proc Soc Exp Biol Med. 1975 Nov; 150(2):337-9.
    View in: PubMed
  143. Dolin R, Smith HA. Antiviral activity of adenine arabinoside and iododeoxyuridine in human fetal intestinal and tracheal organ cultures. J Infect Dis. 1975 Sep; 132(3):287-95.
    View in: PubMed
  144. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, Kapikian AZ, Chanock RM. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis. 1974 Jun; 129(6):709-14.
    View in: PubMed
  145. Agus SG, Falchuk ZM, Sessoms CS, Wyatt RG, Dolin R. Increased jejunal IgA synthesis in vitro during acute infectious nonbacterial gastroenteritis. Am J Dig Dis. 1974 Feb; 19(2):127-31.
    View in: PubMed
  146. Buscho R, Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Chanock RM. Recurrent institutional outbreaks of acute infectious nonbacterial gastroenteritis: epidemiology and etiology. Am J Epidemiol. 1973 Sep; 98(3):192-8.
    View in: PubMed
  147. Carter BJ, Koczot FJ, Garrison J, Rose JA, Dolin R. Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication. Nat New Biol. 1973 Jul 18; 244(133):71-3.
    View in: PubMed
  148. Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS. Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann Intern Med. 1973 Jul; 79(1):18-25.
    View in: PubMed
  149. Wyatt RG, Kalica AR, Dolin R. Ultrastructural study of viral replication in human fetal intestinal organ culture. Arch Gesamte Virusforsch. 1973; 40(3):341-9.
    View in: PubMed
  150. Dolin R, Rabson AS. Herpesvirus saimiri: enhancement of adenovirus-associated virus. J Natl Cancer Inst. 1973 Jan; 50(1):205-8.
    View in: PubMed
  151. Dolin R, Blacklow NR, Wyatt RG, Sereno MM. Detection and localization of viruses in human fetal intestinal organ cultures by immunofluorescence. Infect Immun. 1972 Dec; 6(6):958-64.
    View in: PubMed
  152. Kapikian AZ, Wyatt RG, Dolin R, Thornhill TS, Kalica AR, Chanock RM. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol. 1972 Nov; 10(5):1075-81.
    View in: PubMed
  153. Dolin R, Blacklow NR, DuPont H, Buscho RF, Wyatt RG, Kasel JA, Hornick R, Chanock RM. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med. 1972 Jun; 140(2):578-83.
    View in: PubMed
  154. Dolin R, Blacklow NR, DuPont H, Formal S, Buscho RF, Kasel JA, Chames RP, Hornick R, Chanock RM. Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis. 1971 Mar; 123(3):307-12.
    View in: PubMed
  155. Blacklow NR, Dolin R, Hoggan MD. Studies of the enhancement of an adenovirus-associated virus by herpes simplex virus. J Gen Virol. 1971 Jan; 10(1):29-36.
    View in: PubMed
  156. Dolin R, Blacklow NR, Malmgren RA, Chanock RM. Establishment of human fetal intestinal organ cultures for growth of viruses. J Infect Dis. 1970 Sep; 122(3):227-31.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Dolin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (530) concept(s)
_
Co-Authors
See all (19) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_